(Q81045797)
Statements
Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides (English)
Lena Innala
Heidi Kokkonen
Catharina Eriksson
Erik Jidell
Solbritt Rantapää Dahlqvst